“We expect Tesla to meaningfully increase its robotaxi fleet size in 2026,” Morgan Stanley wrote. While Tesla has taken a cautious approach in Austin and San Francisco, the bank expects the fleet to ...

Investing.com -- Riley Exploration Permian Inc (NYSE:REPX) stock rose 6.6% after-hours Tuesday following the company’s announcement of a $100 million share repurchase program.

Investing.com -- Jared Kushner’s Affinity Partners has withdrawn from the takeover battle for Warner Bros. Discovery, according to a report from Bloomberg News, citing a statement.

According to the report, Warner Bros. Discovery plans to tell shareholders as soon as Wednesday to reject Paramount’s latest offer and instead support its existing deal with Netflix (NASDAQ:NFLX). The ...

Dec 8 (Reuters) - Medical supplies giant Medline said on Monday it was targeting an up to $39.5 billion valuation in its ...

Consorcio Petrolero 5M del Golfo won two contracts in the bidding process while Geolis, Petrolera Miahuapan and Cesigsa won ...

Investing.com -- E.W. Scripps Co (NASDAQ:SSP) stock fell 8.5% in after-hours trading Tuesday after the company announced its board of directors unanimously rejected an unsolicited acquisition proposal ...

Investing.com -- Children’s Place Inc. (NASDAQ:PLCE) reported a significant earnings miss for its third quarter, with both ...

Investing.com -- Fitch Ratings has affirmed Cosan S.A. ’s Long-Term Foreign and Local Currency Issuer Default Ratings (IDRs) ...

Investing.com -- Spirit Aviation Holdings Inc. is in discussions to merge with Frontier Group Holdings , according to a Tuesday report from Bloomberg, citing people familiar with the matter.

COLUMBUS - Worthington Enterprises Inc. (NYSE:WOR) reported second-quarter fiscal 2026 adjusted earnings that fell short of analyst expectations, sending shares down 7.2% Tuesday as investors reacted ...

Investing.com -- DBV Technologies (NASDAQ:DBVT) stock soared 65.2% in after-hours trading Tuesday following the announcement of positive topline results from its Phase 3 VITESSE trial for the VIASKIN ...